| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 98.084 | 148.174 | 136.361 | 197.787 | 155.785 | 148.819 | 308.605 | 425.151 | 466.408 |
| Total Income - EUR | - | 98.084 | 148.448 | 136.361 | 197.787 | 155.785 | 148.819 | 312.576 | 453.437 | 488.024 |
| Total Expenses - EUR | - | 16.934 | 24.811 | 32.019 | 29.741 | 21.754 | 29.141 | 15.917 | 23.703 | 41.416 |
| Gross Profit/Loss - EUR | - | 81.150 | 123.637 | 104.343 | 168.046 | 134.031 | 119.678 | 296.660 | 429.734 | 446.608 |
| Net Profit/Loss - EUR | - | 78.207 | 118.549 | 100.252 | 162.456 | 130.460 | 117.053 | 294.158 | 426.047 | 431.967 |
| Employees | - | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 |
Check the financial reports for the company - Cardiosave Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 41.587 | 32.533 | 24.542 | 19.875 | 9.110 | 11.122 | 9.683 | 8.290 | 89.223 |
| Current Assets | - | 69.114 | 100.607 | 83.571 | 146.350 | 124.231 | 108.566 | 285.270 | 419.323 | 380.827 |
| Inventories | - | 4 | 0 | 0 | 541 | 325 | 117 | 0 | 0 | 0 |
| Receivables | - | 56.735 | 40.041 | 16.960 | 45.961 | 104.323 | 107.159 | 285.086 | 362.342 | 335.091 |
| Cash | - | 12.375 | 60.566 | 66.611 | 99.848 | 19.584 | 1.290 | 184 | 56.980 | 45.736 |
| Shareholders Funds | - | 78.252 | 118.602 | 100.303 | 162.506 | 130.510 | 117.101 | 294.207 | 426.096 | 432.015 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 32.855 | 14.913 | 7.901 | 4.426 | 3.178 | 3.080 | 1.602 | 1.947 | 38.518 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Cardiosave Srl